Make Better Decisions

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

McKinsey
Cantor Fitzgerald
Cipla
QuintilesIMS
Mallinckrodt
Citi
Colorcon
Dow
Queensland Health
Argus Health

Generated: January 18, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 202880

« Back to Dashboard

NDA 202880 describes ZOHYDRO ER, which is a drug marketed by Pernix Ireland Pain and is included in one NDA. It is available from two suppliers. There are thirteen patents protecting this drug and one Paragraph IV challenge. Additional details are available on the ZOHYDRO ER profile page.

The generic ingredient in ZOHYDRO ER is hydrocodone bitartrate. There are twenty-two drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the hydrocodone bitartrate profile page.
Summary for 202880
Tradename:ZOHYDRO ER
Applicant:Pernix Ireland Pain
Ingredient:hydrocodone bitartrate
Patents:13
Formulation / Manufacturing:see details
Pharmacology for NDA: 202880
Mechanism of ActionOpioid Agonists
Medical Subject Heading (MeSH) Categories for 202880
Suppliers and Packaging for NDA: 202880
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
ZOHYDRO ER hydrocodone bitartrate CAPSULE, EXTENDED RELEASE;ORAL 202880 NDA Zogenix, Inc. 43376-210 43376-210-10 100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (43376-210-10)
ZOHYDRO ER hydrocodone bitartrate CAPSULE, EXTENDED RELEASE;ORAL 202880 NDA Zogenix, Inc. 43376-215 43376-215-10 100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (43376-215-10)

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:CAPSULE, EXTENDED RELEASE;ORALStrength10MG
Approval Date:Oct 25, 2013TE:RLD:Yes
Regulatory Exclusivity Expiration:Oct 25, 2016
Regulatory Exclusivity Use:NEW PRODUCT
Patent:➤ SubscribePatent Expiration:Nov 1, 2019Product Flag?YSubstance Flag?Delist Request?
Patent:➤ SubscribePatent Expiration:Nov 1, 2019Product Flag?YSubstance Flag?Delist Request?

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Chubb
Farmers Insurance
Mallinckrodt
Healthtrust
Dow
Queensland Health
Daiichi Sankyo
Fish and Richardson
Chinese Patent Office

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot